Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease

New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk

(2015) Bhavin B. Adhyaru et al.   CARDIOLOGY CLINICS

Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease

(2015) Ioannis E. Koutroubakis et al.   Clinical Gastroenterology and Hepatology

Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy

(2015) José Miranda-Bautista et al.   DIGESTIVE DISEASES AND SCIENCES

The Influence of Anti–tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease

(2015) Ioannis E. Koutroubakis et al.   INFLAMMATORY BOWEL DISEASES

Apolipoprotein C-III

(2015) Alison B. Kohan   Current Opinion in Endocrinology Diabetes and Obesity

Epidemiology, risk factors and management of cardiovascular diseases in IBD

(2014) Siddharth Singh et al.   Nature Reviews Gastroenterology & Hepatology

Association Between Telephone Activity and Features of Patients With Inflammatory Bowel Disease

(2013) Claudia Ramos–Rivers et al.   Clinical Gastroenterology and Hepatology

Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

(2013) Jamie Robertson et al.   Nature Reviews Rheumatology

Trends in Lipids and Lipoproteins in US Adults, 1988-2010

(2012) Margaret D. Carroll et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study*

(2011) Seth D. Crockett et al.   INFLAMMATORY BOWEL DISEASES

Overall Mortality, Incremental Life Expectancy, and Cause of Death at 25 Years in the Program on the Surgical Control of the Hyperlipidemias

(2010) Henry Buchwald et al.   ANNALS OF SURGERY

Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease

(2010) Raja Shekhar R. Sappati Biyyani et al.   Journal of Clinical Lipidology

Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease

(2009) Ioannis E. Koutroubakis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Plasma lipids and inflammation in active inflammatory bowel diseases

(2008) G. ROMANATO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Lipid and phospholipid profile after bowel resection for Crohn’s disease

(2008) Giovanna Romanato et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE